(Q38166204)

30 August 2017

title

Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases (English)

1 reference

30 August 2017

1 reference

1

Pier Luigi Meroni

1 reference

30 August 2017

6

Maria Orietta Borghi

1 reference

30 August 2017

2

Martina Biggioggero

1 reference

30 August 2017

3

Silvia S Pierangeli

1 reference

30 August 2017

Joanna Sheldon

4

1 reference

30 August 2017

Ingrid Zegers

series ordinal

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

26 November 2013

1 reference

Nature Reviews Rheumatology

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

35-43

1 reference

Tight disease control in early RA.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Anti-CCP antibodies: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener’s autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Epitope specificity and significance in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

21 January 2018

Monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Monoclonal antibodies to the thyrotropin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Catastrophic antiphospholipid syndrome: updated diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Does seronegative antiphospholipid syndrome really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Diagnostic performance and predictive value of anti-citrullinated peptide antibodies for diagnosis of rheumatoid arthritis: toward more accurate detection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Diagnosis of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Predictive value of anti-dsDNA autoantibodies: importance of the assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Drug-induced lupus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The influence of ACPA status and characteristics on the course of RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Standardization of protein biomarker measurements: is it feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

ANA screening: an old test with new recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Autoantibodies as predictive tools in systemic sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Are anti-C1q antibodies different from other SLE autoantibodies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Antiphospholipid antibodies and the protein C pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.180

Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models

31 March 2020

1 reference

12 December 2020

Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria

1 reference

12 December 2020

Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study.

1 reference

12 December 2020

Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse

1 reference

12 December 2020

Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2013.180

1 reference

Dimensions Publication ID

30 August 2017

1004095452

0 references

1 reference